Insider Transactions in Q2 2024 at Ptc Therapeutics, Inc. (PTCT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 22
2024
|
Jerome B Zeldis |
SELL
Open market or private sale
|
Direct |
20,000
-57.97%
|
$760,000
$38.24 P/Share
|
|
May 22
2024
|
Jerome B Zeldis |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+36.7%
|
$520,000
$26.42 P/Share
|
|
May 08
2024
|
David P Southwell |
SELL
Bona fide gift
|
Direct |
1,650
-11.38%
|
-
|
|
May 07
2024
|
Lee Scott Golden EVP & CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
175
-0.29%
|
$5,600
$32.82 P/Share
|
|
Apr 19
2024
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,361
-1.47%
|
$80,664
$24.89 P/Share
|
|
Apr 17
2024
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,307
-0.57%
|
$32,675
$25.14 P/Share
|
|
Apr 17
2024
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
787
-1.15%
|
$19,675
$25.14 P/Share
|
|
Apr 02
2024
|
Lee Scott Golden EVP & CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
526
-0.87%
|
$14,728
$28.37 P/Share
|